Everolimus Versus MMF in Lung Transplant Recipients

Trial Profile

Everolimus Versus MMF in Lung Transplant Recipients

Completed
Phase of Trial: Phase II

Latest Information Update: 21 Apr 2012

At a glance

  • Drugs Everolimus (Primary) ; Mycophenolate mofetil (Primary) ; Ciclosporin; Prednisolone
  • Indications Bronchiolitis obliterans; Lung transplant rejection
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 21 Apr 2012 Primary endpoint results presented at the 32nd Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation.
    • 21 Apr 2012 Additional descriptors, treatment table details, study initiation and completion dates, patient numbers (updated from 100 to 190) and primary study endpoint added
    • 21 Apr 2012 Status changed from active, no longer recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top